CityU young scholar’s research on rare cells brings hope to new cancer immunotherapy and vaccine

Description

Cancer immunotherapy has drawn increasing attention in recent years. Although still at its infancy, it has brought hope to many cancer patients. Exploring the anti-tumour activities of a rare immune cell type in the human body is the focus of a research project led by a biomedical scientist and her research team at City University of Hong Kong (CityU). The research findings will provide insights into designing new generations of cancer immunotherapy and vaccine against different cancers.